These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17826189)

  • 1. Pulmonary and cardiac infections in athletes.
    Kruse RJ; Cantor CL
    Clin Sports Med; 2007 Jul; 26(3):361-82. PubMed ID: 17826189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upper respiratory tract infections in athletes.
    Page CL; Diehl JJ
    Clin Sports Med; 2007 Jul; 26(3):345-59. PubMed ID: 17826188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal infections in the athlete.
    Karageanes SJ
    Clin Sports Med; 2007 Jul; 26(3):433-48. PubMed ID: 17826194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious disease and the collegiate athlete.
    Hosey RG; Rodenberg RE
    Clin Sports Med; 2007 Jul; 26(3):449-71. PubMed ID: 17826195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious and lymphocytic myocarditis: epidemiology and factors relevant to sports medicine.
    Friman G; Wesslén L; Karjalainen J; Rolf C
    Scand J Med Sci Sports; 1995 Oct; 5(5):269-78. PubMed ID: 8581569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary infections in the athlete.
    Smoot MK; Hosey RG
    Curr Sports Med Rep; 2009; 8(2):71-5. PubMed ID: 19276906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental and infectious conditions in sports.
    Weber TS
    Clin Sports Med; 2003 Jan; 22(1):181-96. PubMed ID: 12613093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Grepafloxacin (Vaxar)--innovative antibiotic for therapy of respiratory tract infections. Symposium: "Grepafloxacin--a new quinolone designed for respiratory tract infection. Lausanne/Switzerland, 25 May 1997].
    Pneumologie; 1997 Sep; 51(9 Suppl):1-4. PubMed ID: 9417540
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous fungal and viral infections in athletes.
    Pleacher MD; Dexter WW
    Clin Sports Med; 2007 Jul; 26(3):397-411. PubMed ID: 17826191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial agents for myocarditis: target the pathway, not the pathogen.
    Blauwet LA; Cooper LT
    Heart; 2010 Apr; 96(7):494-5. PubMed ID: 19617212
    [No Abstract]   [Full Text] [Related]  

  • 11. Respiratory infections.
    Anderson EJ
    Cancer Treat Res; 2014; 161():203-36. PubMed ID: 24706226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging respiratory tract infections.
    Zumla A; Hui DS; Al-Tawfiq JA; Gautret P; McCloskey B; Memish ZA
    Lancet Infect Dis; 2014 Oct; 14(10):910-1. PubMed ID: 25189348
    [No Abstract]   [Full Text] [Related]  

  • 13. Respiratory infections.
    Cant AJ; Gordon SB; Read RC; Hart CA; Winstanley C
    J Med Microbiol; 2002 Nov; 51(11):903-914. PubMed ID: 12448673
    [No Abstract]   [Full Text] [Related]  

  • 14. Infectious Dermatoses in Sport: A Review of Diagnosis, Management, and Return-to-Play Recommendations.
    Paradise SL; Hu YE
    Curr Sports Med Rep; 2021 Feb; 20(2):92-103. PubMed ID: 33560033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guideline for treatment respiratory infections].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2009 Dec; 32(12):437. PubMed ID: 20088344
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new quinolone (pefloxacine) in bronchopulmonary superinfections in cystic fibrosis].
    Reineri P; Squinazi F; Tobelem R; Lemerle S; Lobut JB; Bernaudin F; Kohout G; Bouveret
    Pediatrie; 1984; 39(7):597-8. PubMed ID: 6598489
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosing COVID-19 myocarditis in athletes using cMRI.
    Patel P; Thompson PD
    Trends Cardiovasc Med; 2022 Apr; 32(3):146-150. PubMed ID: 34954013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ofloxacin in cystic fibrosis.
    Meyer H
    Drugs; 1987; 34 Suppl 1():177-9. PubMed ID: 3481319
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimicrobial treatment of acute bacterial pulmonary infections. A statement by the Committee on therapy.
    Am Rev Respir Dis; 1968 Oct; 98(4):732-6. PubMed ID: 5677162
    [No Abstract]   [Full Text] [Related]  

  • 20. New agents to treat lung infection in cystic fibrosis: a big enough leap?
    Hurley M; Smyth A
    Future Med Chem; 2013 Feb; 5(2):117-20. PubMed ID: 23360136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.